Anyone have any thoughts on the recent rise in price?

Whatman profit hit by accounting error
MoneyAM
Life sciences company Whatman said its full-year earnings before interest, tax and amortisation are expected to be slightly lower than current market expectations.

The company said somewhat slower sales growth will affect its operating margins.

The company's profits for the year will be adversely affected by 600,000 due to the discovery of an accounting error in the recording of stock in its US operations, Whatman said in a trading statement.

The company narrowed its full-year revenue growth forecast range to 6-7 pct from the previous 6%-8%.

Revenues during the first half increased 8% compared to the same period in 2005, excluding the effect of exchange rate movements, it said.

'In the second half, we have seen an overall softening in the market and it has taken longer than anticipated to rebuild customer volumes following the disruption resulting from the restructuring of our manufacturing facilities last year,' Whatman added

Is it time to buy?